Clayface has begun its theatrical run with an estimated $43 million worldwide, taking the top box-office position and giving the DC Universe’s most deliberately squishy experiment a genuinely sturdy first weekend. The total consists of $24 million domestically and $19 million from international markets.

That is an encouraging opening, especially for a film reported to have a $44 million production budget. It is not a declaration of final victory—opening-weekend revenue is only one part of a movie’s financial life, and marketing, theater splits, and future attendance all matter—but it gives this dark, R-rated Gotham story a much healthier early runway than its risk profile might have suggested.

There was reason to wonder how audiences would respond. Clayface is not built around a familiar cape-and-quips formula. It focuses on Matt Hagen, played by Tom Rhys Harries, as he tries to put his life back together following an attack that leaves his face scarred. The movie frames the emergence of its title character through brutal body-horror material, making it one of the most adult-oriented corners of the shared DCU so far.

In other words, a Batman-adjacent villain film with an R rating went to theaters in October and asked viewers to confront a horrifying transformation. Audiences appear to have accepted the invitation—possibly while looking at their popcorn with new suspicion.

A promising start, not a final box-office verdict

The useful way to read the $43 million figure is as a positive opening signal rather than a completed balance sheet. The reported $44 million budget means the worldwide opening is close to the film’s production cost, but theatrical grosses are not the same as money returned to the studio. Cinemas retain a portion of ticket revenue, and a movie’s overall costs extend beyond production.

Still, the comparison is meaningful because Clayface did not need to arrive with the enormous financial burden of a tentpole budget. Its performance is notably different in scale from Supergirl, the Milly Alcock-led DCU release that premiered in June. That movie’s nearly $200 million budget stood far above its eventual $126.46 million theatrical total, making it a difficult proposition financially.

Clayface therefore illustrates a practical point for franchise filmmaking: a recognizable universe can support projects with very different tones and financial stakes. The question is not whether every DCU title must resemble the brightest, biggest superhero releases. It is whether each movie has an audience proposition clear enough to justify its cost. Here, the proposition is unusually direct: Gotham, mutation, tragedy, and hard-R body horror.

Its opening suggests there is an audience for that proposition. Whether the film develops the staying power needed for a clear success will depend on how sharply attendance holds in the weeks ahead.

Why the October calendar could matter

Release timing gives Clayface a potentially valuable advantage. With Halloween approaching, audiences seeking something frightening have a new theatrical option whose horror identity is central rather than incidental. That does not guarantee continued ticket sales, but it gives the film a natural reason to remain in the conversation during a season when frightening stories are especially appealing.

The film also has early reception indicators on its side. It holds a 75% critics score and a 94% audience score on Rotten Tomatoes. These are different measures: the critics figure represents published reviews collected by the site, while the audience figure reflects participating viewers. Neither score can independently predict a final box-office result, but the large audience number is a notable early sign for a film asking comic-book viewers to follow it into far uglier territory than usual.

CinemaScore, which surveys audiences after theatrical screenings, produced an A- grade for the film. That is particularly striking in a horror context, where punishing or unsettling material can make broad audience enthusiasm harder to obtain. DC Studios co-chair James Gunn highlighted the result in a post, noting that only a small number of recent horror films had landed an A- CinemaScore and naming Obsession and Weapons alongside Clayface.

“Really proud of this,” Gunn wrote, praising director James Watkins, writers Mike Flanagan and Hossein Amini, Harries, Naomi and the wider team.

That reaction matters less as a victory lap than as a reminder of what the number implies: people who actually bought tickets were broadly favorable toward the experience. Strong audience response can support word of mouth, the informal recommendation cycle that may help a movie retain viewers after its opening surge. It cannot make a film immune to normal theatrical drop-offs, but it is much better to have patrons recommending the nightmare than warning friends away from it.

How an R-rated horror story fits the wider DCU

The bigger creative issue around Clayface has been tonal compatibility. The DCU has already shown a brighter, more openly hopeful side through 2025’s Superman. A visceral, scarred-origin tragedy set in Gotham occupies a radically different emotional register.

That contrast is not automatically a contradiction. A shared universe does not require every installment to use the same genre language. “Body horror” is a term for horror that focuses on disturbing transformations, injury, mutation, or vulnerability of the human body. In Clayface, that approach is tied to Matt Hagen’s attack and attempted reconstruction of his life, making the horror part of the character’s origin rather than simply an ornamental visual choice.

The early commercial response indicates that a DCU label can stretch to include that kind of genre specificity. The actual long-term test will be whether viewers see the variety as a feature rather than a confusing detour. For now, the film’s opening gives the experiment something important: evidence that an adult-focused Gotham tale can pull people in without trying to sand away its strangest edges.

It also gives attention to a character who has often existed outside the very top tier of Batman’s live-action rogues. Choosing Matt Hagen rather than a more frequently adapted villain appears to have offered room for a different kind of character-led horror story. Harries plays the central role, Watkins directs, and Flanagan and Amini are credited as writers.

The rest of the weekend: documentary growth and a tough equation for Wildwood

Clayface led a weekend with very different theatrical bets below it. In second place domestically, Nathan Fielder and Lance Oppenheim’s Elizabeth Holmes documentary You Can See Everything added $19.5 million in its second weekend. The three-hour film increased 25% from its debut after expanding into 1,800 additional theaters.

That increase is a reminder that a limited opening and a wide opening are not directly comparable. A film debuting in fewer cinemas has less initial capacity to sell tickets; expanding availability can generate growth even after release week. For You Can See Everything, positive notices and early earnings appear to have supported the wider rollout. The story examines Holmes and Theranos, and its performance suggests viewers are willing to make time for a long documentary when the subject and early response create enough curiosity.

Laika’s stop-motion fantasy Wildwood, directed by Travis Knight, placed third domestically with $11.77 million. The number came in above projections, but the reported $100 million budget creates a much steeper challenge than the one facing Clayface. A strong review profile does not erase that arithmetic. Wildwood has a 100% critics score and 97% audience score on Rotten Tomatoes, yet the initial box-office total sits far from the kind of start that would make recouping a nine-figure budget look straightforward.

There is a useful distinction here between reception and revenue. Reviews address how the work is received by critics and viewers; box office tracks ticket sales. A movie can be celebrated and still struggle commercially if attendance does not scale to match its cost. Conversely, an early sales surge does not establish enduring acclaim. Both measures add context, but neither tells the whole story alone.

Elsewhere, Street Fighter collected another $16.8 million worldwide in its second weekend. Wicker, starring Alexander Skarsgård and Olivia Colman, brought in $5.75 million domestically in its more limited opening weekend.

What to watch next for Clayface

The next few weekends will provide the better answer to the only question that really remains: can Clayface turn an impressive launch into a durable theatrical run? Its October positioning, horror appeal, high audience score, and A- CinemaScore are all constructive signs. Yet none removes the usual uncertainty around second-weekend declines, international momentum, or the drawing power of competing releases.

For the DCU, however, the immediate picture is substantially brighter than the pre-release nerves surrounding the movie’s tonal extremity. The film has opened at No. 1, approached its reported production budget in global ticket sales from its first weekend, and earned encouraging responses from the audiences leaving the theater.

That does not mean every future DC project should become a grotesque R-rated transformation tale. It does suggest that franchise cohesion does not have to mean uniformity. A universe containing hopeful superhero spectacle can apparently make room for a bleak Gotham horror story, provided the movie commits to its identity and viewers see a reason to show up. In Clayface’s case, they did—and in numbers that make this particular monster look considerably less scary to the accountants.

For more DCU context, see our coverage of Green Lantern #40 and its DCU-shaking secret.